MYRIAD GENETICS INC
MYGNNASDAQ🏆 #3113 by market capEarnings Nov 2US Equity
$3.14▼ $0.08 (−2.64%)
Live1h▲ 0.0%
24h▼ 2.6%
7d▼ 0.6%
14d▼ 37.7%
30d▼ 46.6%
1y▼ 48.0%
🏦Market Cap
$296M
Small Cap
📈Revenue Growth (YoY)
-3.2%
Declining
📊Gross Margin
68.8%
High
💵FCF Margin
2.4%
Thin
⚖️P/S Ratio
0.4x
Cheap
Otter Score
48
Weak
📊
Analyst Ratings
Price
$3.14
Total
36
Raised
2
Lowered
11
Avg PT
$4.50
H / L
$6 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Reiterated | Hold | 2026-07-31 |
Wells Fargo | Reiterated | Equal Weight | 2026-05-06 |
UBS | Reiterated | Neutral | 2026-02-24 |
Piper Sandler | Reiterated | Overweight | 2025-11-11 |
Scotiabank | Downgraded | Sector Outperform → Sector Perform | 2025-05-21 |
Goldman Sachs | Reiterated | Buy | 2025-05-07 |
Raymond James | Reiterated | Outperform | 2025-05-07 |
Guggenheim | Downgraded | Buy → Neutral | 2025-04-09 |
B of A Securities | Reiterated | Underperform | 2025-03-03 |
Stephens & Co. | Reiterated | Equal Weight | 2025-01-16 |
Leerink Partners | Downgraded | Outperform → Market Perform | 2024-12-09 |
Morgan Stanley | Reiterated | Equal Weight | 2024-11-18 |
JP Morgan | Reiterated | Underweight | 2024-08-07 |
SVB Leerink | Reiterated | Market Perform | 2022-11-02 |
Barclays | Reiterated | Underweight | 2020-03-26 |
Bank of America | Downgraded | Neutral → Underperform | 2019-09-26 |
Piper Jaffray | Downgraded | Overweight → Equal Weight | 2019-08-14 |
Deutsche Bank | Reiterated | Hold | 2019-08-14 |
Needham | Downgraded | Strong Buy → Hold | 2019-07-29 |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2019-07-09 |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-10-10 |
Leerink Swann | Reiterated | Market Perform | 2018-08-28 |
BTIG Research | Reiterated | Buy | 2018-01-05 |
Ladenburg Thalmann | Upgraded | Sell → Neutral | 2017-02-08 |
Jefferies | Reiterated | Hold | 2016-08-11 |
Gabelli & Co. | Downgraded | Buy → Hold | 2016-08-10 |
Avondale Partners | Reiterated | Market Outperform | 2016-05-04 |
JMP Securities | Reiterated | Market Outperform | 2015-08-12 |
Credit Suisse | Downgraded | Neutral → Underperform | 2015-02-04 |
Mizuho | Downgraded | Buy → Neutral | 2015-02-04 |
Macquarie | Reiterated | Neutral | 2014-06-05 |
SunTrust Robinson Humphrey | Reiterated | Reduce → Sell | 2013-10-11 |
RBC Capital | Downgraded | Outperform → Sector Perform | 2013-06-14 |
Cantor Fitzgerald | Reiterated | Buy | 2013-06-06 |
Oppenheimer | Reiterated | Perform | 2013-03-04 |
Bank oferica | Reiterated | Neutral | 2012-05-11 |
One row per institution, most recent rating